![Eimear Moloney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eimear Moloney
Directeur/Membre du Conseil chez
KINGSPAN GROUP PLC
Fortune : 810 406 $ au 31/07/2026
Profil
Eimear Grainne Moloney is currently an Independent Non-Executive Director at Kingspan Group Plc since 2021, an Independent Non-Executive Director at Irish Continental Group Plc since 2022, a Director at Chanelle Pharmaceuticals Manufacturing Ltd., a Non-Executive Director at De Burgo Pharma Group Ltd. since 2019, and a Member of the Institute of Directors In Ireland.
Former roles include Associate Director-Global Equities at Zurich Life Assurance Plc, Independent Non-Executive Director at Ravelin Ireland YG Ltd. from 2018 to 2022, and Senior Independent Director at Hostelworld Group Plc from 2025 to 2026.
Education includes undergraduate and graduate degrees from Dublin City University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 50 000 ( 0,03 % ) | 454 468 $ | 31/07/2026 | |
| 31/12/2024 | 2 000 ( 0 % ) | 184 663 $ | 31/07/2026 | |
| 31/12/2025 | 122 376 ( 0,1 % ) | 171 275 $ | 31/07/2026 |
Postes actifs de Eimear Moloney
| Sociétés | Poste | Début |
|---|---|---|
| KINGSPAN GROUP PLC | Directeur/Membre du Conseil | 30/04/2021 |
| IRISH CONTINENTAL GROUP PLC | Directeur/Membre du Conseil | 25/08/2022 |
Institute of Directors In Ireland
 Institute of Directors In Ireland Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
Chanelle Pharma Group Ltd.
 Chanelle Pharma Group Ltd. Pharmaceuticals: GenericHealth Technology Operates as generic drug maker | Directeur/Membre du Conseil | 01/03/2019 |
Chanelle Pharmaceuticals Manufacturing Ltd.
 Chanelle Pharmaceuticals Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic animal pharmaceutical products | Directeur/Membre du Conseil | - |
Anciens postes connus de Eimear Moloney
| Sociétés | Poste | Fin |
|---|---|---|
| HOSTELWORLD GROUP PLC | Directeur/Membre du Conseil | 23/07/2026 |
| YEW GROVE REIT PLC | Directeur/Membre du Conseil | 07/02/2022 |
Zurich Life Assurance Plc
 Zurich Life Assurance Plc Investment ManagersFinance Zurich Life invests globally across asset classes and does not strongly adhere to a particular investment style. They offer a wide range of funds: (1) multi-asset funds generally invest in a range of assets, countries and market sectors, diversifying the client’s investment across many different asset classes in order to minimize risk; (2) cash and bond funds; (3) equity funds; (4) property funds can give two types of return: capital growth on the value of a property, and rental income; (5) dimensional funds; and (6) alternative investment which include precious metals such as gold and copper, as well as investments in water infrastructure and agriculture. | Gestionnaire de Portefeuille-Actions | - |
Formation de Eimear Moloney
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Kingspan Group Plc
 Kingspan Group Plc Construction MaterialsNon-Energy Minerals Manufactures insulated panels, piping insulation and ducting insulation products | Non-Energy Minerals |
Irish Continental Group Plc
 Irish Continental Group Plc Marine ShippingTransportation Operates ferries and containers & terminals | Transportation |
Zurich Life Assurance Plc
Zurich Life Assurance Plc Investment ManagersFinance Zurich Life invests globally across asset classes and does not strongly adhere to a particular investment style. They offer a wide range of funds: (1) multi-asset funds generally invest in a range of assets, countries and market sectors, diversifying the client’s investment across many different asset classes in order to minimize risk; (2) cash and bond funds; (3) equity funds; (4) property funds can give two types of return: capital growth on the value of a property, and rental income; (5) dimensional funds; and (6) alternative investment which include precious metals such as gold and copper, as well as investments in water infrastructure and agriculture. | Finance |
Chanelle Pharma Group Ltd.
Chanelle Pharma Group Ltd. Pharmaceuticals: GenericHealth Technology Operates as generic drug maker | Health Technology |
Chanelle Pharmaceuticals Manufacturing Ltd.
Chanelle Pharmaceuticals Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic animal pharmaceutical products | Health Technology |
Dublin City University
 Dublin City University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Directors In Ireland
Institute of Directors In Ireland Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Hostelworld Group Plc
 Hostelworld Group Plc Other Consumer ServicesConsumer Services Provides online hotel and hostel reservation services | Consumer Services |
Yew Grove REIT Plc
 Yew Grove REIT Plc Real Estate Investment TrustsFinance Acts as a Real Estate Investment Trust/REIT | Finance |
